Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
BridgeBio Pharma
BBIO
$15.9B
| $4.66M | ﹤0.01% |
133,031
+6,788
| +5% | +$188K |
|
2052
Community Trust Bancorp
CTBI
$1.44B
| $4.64M | ﹤0.01% |
99,400
+1,729
| +2% | +$76.6K |
|
2053
Origin Bancorp
OBK
$1.69B
| $4.64M | ﹤0.01% |
122,525
+2,654
| +2% | +$93K |
|
|
LDL
2054
DELISTED
Lydall, Inc.
LDL
| $4.64M | ﹤0.01% |
225,893
+39,293
| +21% | +$814K |
|
2055
Agilysys
AGYS
$3.25B
| $4.63M | ﹤0.01% |
182,196
+2,922
| +2% | +$73.9K |
|
|
IMGN
2056
DELISTED
Immunogen Inc
IMGN
| $4.61M | ﹤0.01% |
903,495
+18,910
| +2% | +$64.2K |
|
2057
Ichor Holdings
ICHR
$2.67B
| $4.61M | ﹤0.01% |
138,615
+2,505
| +2% | +$74.7K |
|
2058
Akebia Therapeutics
AKBA
$241M
| $4.61M | ﹤0.01% |
728,621
+26,565
| +4% | +$126K |
|
|
HTBK
2059
DELISTED
Heritage Commerce
HTBK
| $4.6M | ﹤0.01% |
358,400
+102,684
| +40% | +$1.25M |
|
|
KBAL
2060
DELISTED
Kimball International
KBAL
| $4.59M | ﹤0.01% |
222,285
-111,021
| -33% | -$2.29M |
|
2061
Century Communities
CCS
$2.04B
| $4.59M | ﹤0.01% |
167,968
+9,037
| +6% | +$264K |
|
2062
Peloton Interactive
PTON
$2.44B
| $4.58M | ﹤0.01% |
+161,411
| New | +$4.35M |
|
|
UBA
2063
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $4.57M | ﹤0.01% |
184,094
+4,667
| +3% | +$112K |
|
2064
GrafTech
EAF
$203M
| $4.57M | ﹤0.01% |
39,304
+700
| +2% | +$88K |
|
2065
Republic Bancorp
RBCAA
$1.92B
| $4.54M | ﹤0.01% |
97,073
+3,459
| +4% | +$156K |
|
|
NFBK
2066
DELISTED
Northfield Bancorp
NFBK
| $4.54M | ﹤0.01% |
267,704
+5,734
| +2% | +$96.3K |
|
2067
Sonic Automotive
SAH
$2.51B
| $4.54M | ﹤0.01% |
146,429
+196
| +0.1% | +$6.2K |
|
2068
Rocket Pharmaceuticals
RCKT
$367M
| $4.54M | ﹤0.01% |
199,333
+11,346
| +6% | +$189K |
|
2069
Stratasys
SSYS
$779M
| $4.53M | ﹤0.01% |
223,990
+39,827
| +22% | +$793K |
|
2070
RPC Inc
RES
$1.39B
| $4.53M | ﹤0.01% |
864,278
+138,087
| +19% | +$619K |
|
|
QUOT
2071
DELISTED
Quotient Technology Inc
QUOT
| $4.52M | ﹤0.01% |
458,351
+16,919
| +4% | +$162K |
|
|
CIO
2072
DELISTED
City Office REIT
CIO
| $4.52M | ﹤0.01% |
334,136
+96,996
| +41% | +$1.29M |
|
|
EB
2073
DELISTED
Eventbrite
EB
| $4.51M | ﹤0.01% |
223,575
+4,374
| +2% | +$83.6K |
|
2074
Donnelley Financial Solutions
DFIN
$1.22B
| $4.5M | ﹤0.01% |
429,879
+16,718
| +4% | +$175K |
|
|
ABTX
2075
DELISTED
Allegiance Bancshares
ABTX
| $4.48M | ﹤0.01% |
119,034
+952
| +0.8% | +$33.5K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.